Gavin Daniel Roach, MD, MS
Cancer and Blood Disorders Center, Hematology
On staff since October 2021
Children's Title: Section Chief, Hematology; Medical Director, Thrombosis Program
Academic Title: Associate Professor, Department of Pediatrics, University of Washington School of Medicine
Research Center: Ben Towne Center for Childhood Cancer Research
"Blood disorders, including hemoglobinopathies, bleeding disorders, clotting disorders, and bone marrow failure syndromes, affect millions of children all over the world. I have been fascinated by blood since the early days of my medical education with a particular interest in the complex systems of bleeding and clotting. I love the detective work that goes into the diagnosis of these disorders and I’m excited about all the novel therapeutic options that are available to our patients, including new medicines and gene therapy. I enjoy being able to work with children and families to offer treatments that can get them back to enjoying a healthy life!"
-
Gavin D. Roach, MD, MS, is an attending physician at Seattle Children’s Hospital, Associate Professor of Pediatrics at the University of Washington School of Medicine, and the Medical Director of the Thrombosis Program at Seattle Children’s. Dr. Roach grew up on the East Coast before moving to Los Angeles for his Pediatrics residency at UCLA. He stayed in LA to complete his hematology/oncology training and then joined the UCLA faculty in 2014. While at UCLA, Dr. Roach was the Director of Pediatric Hematology and oversaw the treatment of all patients with benign hematologic disorders in inpatient and outpatient settings. In addition, he treated patients with bleeding disorders at the Hemophilia Treatment Center at the Orthopaedic Institute for Children in Downtown Los Angeles. He served as the Program Director of the Fellowship Training Program in pediatric hematology/oncology and was involved with medical education at all levels of medical training, including at the David Geffen School of Medicine, in the pediatrics residency training program, and with the pediatric subspecialty fellowship training programs at UCLA.
In 2021, Dr. Roach left sunny Southern California to take on a new position as the Director of Thrombosis at Seattle Children’s. He is looking forward to the opportunity to explore Seattle and the surrounding areas, as well as develop a world-class pediatric thrombosis program serving the children and families of the Pacific Northwest.
-
-
Dr. Roach is excellent. He treated our daughter from 12 day to 12 months old, following a traumatic brain injury resulting from a rare clotting disorder. His demeanor is caring and professional, and his methods are research based. He knows tradition solutions as well as the latest pediatric hematology research, including active studies, and treats both children and parents with utmost respect. He was able to explain in detail our daughter's diagnosis and path forward--including potential alternatives (and limitations of current research). HIs depth of knowledge, honesty and bed-side manner are unlike any of the several dozen doctors we work with. As a mother, I felt compelled to write this review because I wish their was a better way to learn these things about doctors ahead of time. You are in excellent hands with Dr. Roach.
-
-
Award Name Award Description Awarded By Award Date Medical Provider of the Year Award Hemophilia Foundation of Southern California 2021 Pediatric Hematology/Oncology Annual Teaching Award (UCLA) Division of Pediatric Hematology/Oncology 2021 Pediatric Hematology/Oncology Annual Teaching Award (UCLA) Division of Pediatric Hematology/Oncology 2019 Pediatric Hematology/Oncology Annual Teaching Award (UCLA) Division of Pediatric Hematology/Oncology 2016 Daggett Trust Prize Albany Medical College 2008 Alpha Omega Alpha Honor Medical Society Albany Medical College AOA Chapter 2007 -
Manuscripts in Refereed Journals
-
Casillas J, Kao R, Lidington E, Hsu M, Husain S, Roach G, Upadhyay S, Vaghasia N, Gell J, VanDyne E, Li N, Crisci A, Sund G, Danee B, Moore TImproving Fertility Preservation Discussions for Adolescent and Young Adult Male Oncology Patients
Oncology Issues, 2018 Sept. - 2018 Oct. : 33(5)16-26
Other Publications
-
Niss O, Lorsbach RB, Berger M, Chonat S, McLemore M, Buchbinder D, McCavit T, Shaffer LG, Simpson J, Schwartz JH, Meznarich J, Emberesh M, Seu KG, Zhang W, Kalfa TA, CDAR consortium.Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).
33401150 Blood cells, molecules & diseases, 2021 March : 87102534 -
Huen KH, Fong C, Roach G, Singer JIs hyperbilirubinemia a contraindication for neonatal circumcision? A survey of practice patterns of pediatric urologists and a review of the literature.
33268314 Journal of pediatric urology, 2021 Feb. : 17(1)88.e1-88.e6 -
Roach GDPerinatal Arterial Ischemic Stroke.
33139511 NeoReviews, 2020 Nov. : 21(11)e741-e748 -
Friend BD, Roach GD, Kempert PH, Moore TBSuccessful Use of Hematopoietic Stem Cell Transplantation for 2 Pediatric Cases of Glanzmann Thrombasthenia and Review of the Literature.
31693514 Journal of pediatric hematology/oncology, 2020 Aug. : 42(6)e521-e526 -
Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Chalmers E, Simioni P, Bhat RV, Yee DL, Lvova O, Beyer-Westendorf J, Biss TT, Martinelli I, Saracco P, Peters M, Kállay K, Gauger CA, Massicotte MP, Young G, Pap AF, Majumder M, Smith WT, Heubach JF, Berkowitz SD, Thelen K, Kubitza D, Crowther M, Prins MH, Monagle P, EINSTEIN-Jr Phase 3 Investigators.Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
31699660 The Lancet. Haematology, 2020 Jan. : 7(1)e18-e27 -
Bulut Y, Sapru A, Roach GDHemostatic Balance in Pediatric Acute Liver Failure: Epidemiology of Bleeding and Thrombosis, Physiology, and Current Strategies.
33425821 Frontiers in pediatrics, 2020 : 8618119 PMCID:PMC7786276 -
Liu MM, Kohn LA, Roach GD, Sun G, Garcia-Lloret MI, Butte MJTreatment of systemic mastocytosis in an infant with midostaurin.
31154031 The journal of allergy and clinical immunology. In practice, 2019 Nov. : 7(8)2929-2931.e1
-
Overview
- Board Certification(s)
-
Pediatric Hematology-Oncology
- Medical/Professional School
-
Albany Medical College, Albany, NY
Cedars-Sinai Medical Center, West Hollywood, CA - Residency
-
The David Geffen School of Medicine at UCLA, Los Angeles, CA
- Fellowship
-
Mattel Children's Hospital at UCLA Medical Center, Los Angeles, CA
- Clinical Interests
-
Prevention of thrombosis and management of venous thromboembolism (VTE), arterial thrombosis, stroke, and congenital and acquired thrombophilic disorders.
- Research Description
-
The Pediatric Thrombosis Program will demonstrate a commitment to excellence in research through participation in registry studies, investigator-initiated research, and novel therapeutic trials, in order to contribute to the collective knowledge of disorders of pediatric thrombosis.